Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1992-5-19
|
pubmed:abstractText |
Hepatitis B and its sequelae are global problems preventable by immunization. Expense limits the use of hepatitis B vaccines, but low-dose intradermal immunization has been evaluated as a cost-saving strategy in numerous studies. With few exceptions, low-dose intradermal plasma-derived vaccines have elicited protective levels of antibody in 82%-100% of young healthy adults--a proportion similar to that noted with full-dose regimens; peak levels of antibody to hepatitis B surface antigen (HBsAg) are lower with reduced doses, however. Although children respond well to low-dose intradermal immunization, this procedure is technically difficult in neonates and should not be used for those born to HBsAg-positive mothers. For persons at high risk, antibody to HBsAg must be assessed after immunization to determine the need for a booster dose. A fourth dose 1-2 years after the initial series substantially increases antibody concentrations. In low intradermal doses, recombinant vaccine elicits lower rates of seroconversion than plasma-derived vaccine. However, low intramuscular doses of recombinant vaccine give favorable results. In short, low-dose intradermal or intramuscular immunization offers protection against hepatitis B at significant savings and may be useful for mass immunization of populations at high risk.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1058-4838
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
697-707
|
pubmed:dateRevised |
2005-11-16
|
pubmed:meshHeading |
pubmed-meshheading:1532914-Hepatitis B,
pubmed-meshheading:1532914-Hepatitis B Antibodies,
pubmed-meshheading:1532914-Hepatitis B Vaccines,
pubmed-meshheading:1532914-Humans,
pubmed-meshheading:1532914-Immunization,
pubmed-meshheading:1532914-Immunization, Secondary,
pubmed-meshheading:1532914-Injections, Intradermal,
pubmed-meshheading:1532914-Injections, Intramuscular,
pubmed-meshheading:1532914-Vaccines, Synthetic,
pubmed-meshheading:1532914-Viral Hepatitis Vaccines
|
pubmed:year |
1992
|
pubmed:articleTitle |
Low-dose intradermal and intramuscular vaccination against hepatitis B.
|
pubmed:affiliation |
Department of Preventive Medicine and Biometrics, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814.
|
pubmed:publicationType |
Journal Article,
Review
|